Medicare’s ‘Low-Cost’ GLP‑1 Weight-Loss Drugs: Why Coverage Still Isn’t What It Seems
Medicare’s so-called “low-cost” GLP-1 drugs may lure you in, but the truth about their coverage will surprise you. What happens next might change everything.
Crushed by Reimbursement: How Home-Based Care Leaders Survive Relentless Payment Pressure
Home-based care leaders face crushing reimbursement pressures and workforce challenges. How will they adapt to survive this relentless financial storm? The answers may surprise you.